Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Chronic Pain | Access & Reimbursement | Abuse-Deterrent Opioid Analgesics in Chronic Pain | US | 2019
Abuse-deterrent formulations (ADFs) of opioid analgesics entered the U.S. pain market in 2010 as an attempt to slow the increasing rates of abuse/misuse and diversion stemming from chronic use of…
Chronic Pain – Access & Reimbursement – Access & Reimbursement – Abuse-Deterrent Opioid Analgesics in Chronic Pain (US)
Abuse-deterrent formulations (ADFs) of opioid analgesics entered the U.S. pain market in 2010 as an attempt to slow the increasing rates of abuse/misuse and diversion stemming from chronic use of…
Epilepsy | Treatment Algorithms: Claims Data Analysis | Generalized-Onset Seizures | US | 2019
DRG epidemiologists estimate that 40% of epilepsy patients experience generalized-onset seizures (GOS). The most commonly prescribed early-line treatments for GOS are older antiepileptic drugs (…
Chronic Heart Failure | Preserved Ejection Fraction | Treatment Algorithms | Claims Data Analysis | US | 2018
Heart failure with preserved ejection fraction (HFpEF) occurs due to abnormal relaxation and filling of the left ventricle. Despite the fact that HFpEF accounts for nearly half of all CHF cases,…
Attention-Deficit/Hyperactivity Disorder | Current Treatment: Physician Insights | Pediatric ADHD | US | 2019
Attention-deficit/hyperactivity disorder (ADHD) is a common childhood condition that can continue through adolescence and into adulthood. Treatment options include a mix of stimulants (e.g.,…
Attention-Deficit-Hyperactivity Disorder – Current Treatment – Current Treatment: Physician Insights – Pediatric ADHD (US)
Attention-deficit/hyperactivity disorder (ADHD) is a common childhood condition that can continue through adolescence and into adulthood. Treatment options include a mix of stimulants (e.g.,…